COMPARATIVE STUDY
JOURNAL ARTICLE
REVIEW

Type I and II endometrial cancers: have they different risk factors?

Veronica Wendy Setiawan, Hannah P Yang, Malcolm C Pike, Susan E McCann, Herbert Yu, Yong-Bing Xiang, Alicja Wolk, Nicolas Wentzensen, Noel S Weiss, Penelope M Webb, Piet A van den Brandt, Koen van de Vijver, Pamela J Thompson, Brian L Strom, Amanda B Spurdle, Robert A Soslow, Xiao-ou Shu, Catherine Schairer, Carlotta Sacerdote, Thomas E Rohan, Kim Robien, Harvey A Risch, Fulvio Ricceri, Timothy R Rebbeck, Radhai Rastogi, Jennifer Prescott, Silvia Polidoro, Yikyung Park, Sara H Olson, Kirsten B Moysich, Anthony B Miller, Marjorie L McCullough, Rayna K Matsuno, Anthony M Magliocco, Galina Lurie, Lingeng Lu, Jolanta Lissowska, Xiaolin Liang, James V Lacey, Laurence N Kolonel, Brian E Henderson, Susan E Hankinson, Niclas Håkansson, Marc T Goodman, Mia M Gaudet, Montserrat Garcia-Closas, Christine M Friedenreich, Jo L Freudenheim, Jennifer Doherty, Immaculata De Vivo, Kerry S Courneya, Linda S Cook, Chu Chen, James R Cerhan, Hui Cai, Louise A Brinton, Leslie Bernstein, Kristin E Anderson, Hoda Anton-Culver, Leo J Schouten, Pamela L Horn-Ross
Journal of Clinical Oncology 2013 July 10, 31 (20): 2607-18
23733771

PURPOSE: Endometrial cancers have long been divided into estrogen-dependent type I and the less common clinically aggressive estrogen-independent type II. Little is known about risk factors for type II tumors because most studies lack sufficient cases to study these much less common tumors separately. We examined whether so-called classical endometrial cancer risk factors also influence the risk of type II tumors.

PATIENTS AND METHODS: Individual-level data from 10 cohort and 14 case-control studies from the Epidemiology of Endometrial Cancer Consortium were pooled. A total of 14,069 endometrial cancer cases and 35,312 controls were included. We classified endometrioid (n = 7,246), adenocarcinoma not otherwise specified (n = 4,830), and adenocarcinoma with squamous differentiation (n = 777) as type I tumors and serous (n = 508) and mixed cell (n = 346) as type II tumors.

RESULTS: Parity, oral contraceptive use, cigarette smoking, age at menarche, and diabetes were associated with type I and type II tumors to similar extents. Body mass index, however, had a greater effect on type I tumors than on type II tumors: odds ratio (OR) per 2 kg/m(2) increase was 1.20 (95% CI, 1.19 to 1.21) for type I and 1.12 (95% CI, 1.09 to 1.14) for type II tumors (P heterogeneity < .0001). Risk factor patterns for high-grade endometrioid tumors and type II tumors were similar.

CONCLUSION: The results of this pooled analysis suggest that the two endometrial cancer types share many common etiologic factors. The etiology of type II tumors may, therefore, not be completely estrogen independent, as previously believed.

Full Text Links

Find Full Text Links for this Article

Discussion

You are not logged in. Sign Up or Log In to join the discussion.

Related Papers

Remove bar
Read by QxMD icon Read
23733771
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"